Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

prostate cancer, hormone therapy, cardiac risk factors, Yale Cancer Center study, ASTRO 2016
News | Cardio-oncology | September 28, 2016

September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy...

prostate cancer, hypofractionated radiationt therapy, accelerated RT, side effects, treatment time, ASTRO 2016, NRG Oncology/RTOG 0415
News | Prostate Cancer | September 27, 2016

September 27, 2016 — For men with early stage, low-risk...

prostate cancer, novel intrinsic subtypes, study, ASTRO 2016
News | Prostate Cancer | September 26, 2016

September 26, 2016 — In the largest study of its kind to date, researchers have identified and validated three...

ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy
News | Radiation Therapy | September 07, 2016

September 7, 2016 — The American Society for...

Axumin, fluciclovine F-18 injection, first injection, Northside Hospital Atlanta
News | Radiopharmaceuticals and Tracers | September 07, 2016

September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA)...

PRI-MUS protocol, ExactVu micro-ultrasound, prostate cancer, lesion identification, The Journal of Urology study

ExactVu micro-ultrasound system image courtesy of Exact Imaging.

News | Prostate Cancer | August 08, 2016

July 28, 2016 — Exact Imaging announced that The Journal of Urology has published the initial results supporting the...

metastatic prostate cancer incidence, Northwestern Medicine study, Edward Schaeffer, Adam Weiner
Feature | Prostate Cancer | July 25, 2016

July 25, 2016 — The number of new cases of metastatic...

photoacoustic imaging

Images of prostate cells captured through photoacoustic imaging. Top: cancer cells that express the targeted cancer marker, PSMA; bottom: cells that lack PSMA. A research team led by Kent Nastiuk of Roswell Park Cancer Institute has published new evidence that this approach can be a useful tool in monitoring and selecting treatments for many cancers.

News | Prostate Cancer | July 15, 2016

While active surveillance is often recommended for patients with nonaggressive...

PET, mpMRI, prostate cancer detection, targeted biopsies, University of Michigan study, Morand Piert

The figure shows a Gleason 3+4 prostate cancer (arrows) as identified on T2-weighted (A) and diffusion-weighted (B) MRI, F-18-choline PET (C), as well as PET/MRI (D).

News | Prostate Cancer | July 14, 2016

July 14, 2016 — Adding F-18-choline positron...

prostate cancer, MRI-guided biopsies, Overlake Medical Center Washington
News | Prostate Cancer | July 13, 2016

July 13, 2016 — Overlake Medical Center, Bellevue, Wash., recently announced it is formally adopting a new standard...

News | Prostate Cancer | June 17, 2016

June 17, 2016 — Decatur Memorial Hospital, Decatur, Ill., is now offering C-11 choline...

UAB, iSR'obot Mona Lisa, prostate cancer, image-guided biopsy

Jeffrey Nix, M.D., left, and Soroush Rais-Bahrami, M.D., with the iSR’obotTM Mona Lisa , a new image guided device for diagnosing prostate cancer. Image courtesy of UAB News.

News | Biopsy Systems | June 09, 2016

June 9, 2016 — The University of Alabama at Birmingham (UAB) announced it is one of two beta sites in the United...

NaF-PET/CT, sodium fluoride, advanced prostate cancer, metastases, pilot study
News | PET-CT | June 07, 2016

June 7, 2016 — A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium...

Axumin, fluciclovine F-18 injection, PET imaging agent, recurrent prostate cancer, Blue Earth Diagnostics, Siemens PETNET Solutions
Technology | Radiopharmaceuticals and Tracers | June 07, 2016

June 7, 2016 — Blue Earth Diagnostics Ltd. and Siemens’ PETNET Solutions Inc. announced the commercial availability...

prostate cancer, MRI, RSI, restriction spectrum imaging, tumor grade, UC San Diego study

The image on the left is a magnetic resonance image (MRI) of a prostate enhanced with restriction spectrum imaging (RSI). Higher grade tumor is indicated by orange and yellow. The image on the right is a digitized section of the prostate with the tumors outlined with blue dotted lines. Image courtesy of UC San Diego Health.

News | Prostate Cancer | June 02, 2016

June 2, 2016 — Physicians have long used...

prostate cancer, MRI, diagnosis, PRECISE trial, Canada
News | Prostate Cancer | June 01, 2016

June 1, 2016 — A new Phase III clinical trial will look to evaluate if...